Exact Sciences : EEO-1 for the FY ended 12/19/2023
June 29, 2024 at 01:22 am IST
Share
Exact Sciences is committed to disclosing meaningful information regarding our efforts to create a diverse, equitable, and inclusive workplace. To us, diversity means our team reflects a variety of unique identities, cultures, thoughts and lived experiences. With this commitment, we are disclosing our EEO-1 survey data, representing U.S. employees as of December 2023. We note that our EEO-1 survey data present demographic information in federally mandated job categories that don't fully speak to the diversity of our workplace and how we embed diversity, equity, and inclusion into the company . We are firmly committed to providing equal opportunity in all aspects of employment and will not discriminate in any employment decision because of a person's race, color, sex, religion, national origin, age, disability, sexual orientation, gender identity, genetic information, veteran status, or any other basis prohibited by applicable law.
U.S. EQUAL EMPLOYMENT OPPORTUNITY COMMISSION (EEOC)
EEOC Standard Form 100 (SF 100)
Revised 08/2023
2023 EMPLOYER INFORMATION REPORT (EEO-1 COMPONENT 1)
OMB Control Number: 3046-0049
Expiration Date: 11/30/2026
SECTION A - TYPE OF REPORT
CONSOLIDATED REPORT
SECTION B - EMPLOYER IDENTIFICATION
OFS COMPANY ID
EMPLOYER NAME
FN48101
EXACT SCIENCES CORPORATION
ADDRESS
CITY/TOWN
STATE
ZIP CODE
5505 Endeavor Lane
MADISON
WI
53719
SECTION C - HEADQUARTERS OR ESTABLISHMENT-LEVEL IDENTIFICATION (if applicable)
HQ/ESTABLISHMENT-LEVEL UNIT ID
HEADQUARTERS OR ESTABLISHMENT-LEVEL NAME
HEADQUARTERS OR ESTABLISHMENT-LEVEL ADDRESS
CITY/TOWN
STATE
ZIP CODE
SECTION D - EMPLOYER IDENTIFICATION NUMBER (EIN)
020478229
SECTION E - EMPLOYER FILING ELIGIBILITY
□X YES (Employer Is Eligible to File) □ NO (Employer Is Not Eligible to File) □ EMPLOYER NO LONGER IN BUSINESS
SECTION F - FEDERAL CONTRACTOR DESIGNATION (if applicable)
Unique Entity ID (UEI): NGBXEJX5GLE9
YES (Single-Establishment Employer is Federal Contractor) □X YES (Headquarters is Federal Contractor)
□X YES (Multi-Establishment Employer is Federal Contractor)
YES (Non-Headquarters Establishment is Federal Contractor)
□X
YES (One or More Non-Headquarters Establishments is Federal Contractor)
SECTION G - NAICS INFORMATION
621511 - Medical Laboratories
SECTION H - WORKFORCE DEMOGRAPHIC DATA
JA
Race/Ethnicity
Hispanic
Not Hispanic or Latino
or Latino
Male
Female
JOB CATEGORIES
Male
Female
White
AfricanorBlack American
Asian
HawaiianNativeor IslanderPacificOther
AmericanIndianor NativeAlaska
RacesMoreorTwo
White
orBlack AmericanAfrican
Asian
HawaiianNativeor IslanderPacificOther
AmericanIndianor NativeAlaska
RacesMoreorTwo
Row
Total
Executive/Senior Level Officials and Managers
2
1
44
3
4
0
0
0
26
0
2
0
0
0
82
First/Mid-Level Officials and Managers
28
18
403
21
55
1
2
16
381
23
73
0
2
13
1036
Professionals
62
64
715
43
203
3
3
33
865
56
192
3
3
29
2274
Technicians
33
51
213
29
73
3
1
18
184
36
103
0
2
23
769
Sales Workers
17
16
363
15
12
1
0
13
369
8
7
0
0
11
832
Administrative Support Workers
29
71
202
17
19
0
0
15
500
89
62
1
1
41
1047
Craft Workers
1
0
16
6
2
1
0
0
1
1
0
0
0
0
28
Operatives
10
14
91
15
10
0
0
5
41
12
8
0
1
2
209
Laborers and Helpers
1
0
5
0
1
0
0
1
1
0
0
0
0
1
10
Service Workers
2
1
26
4
1
0
0
2
13
3
1
0
0
1
54
CURRENT 2023 REPORTING YEAR TOTAL
185
236
2078
153
380
9
6
103
2381
228
448
4
9
121
6341
PRIOR 2022 REPORTING YEAR TOTAL
175
220
2050
149
338
10
8
106
2386
218
394
2
10
115
6181
SECTION
I -
WORKFORCE SNAPSHOT PERIOD
12/10/2023 - 12/23/2023
SECTION J - HEADQUARTERS OR ESTABLISHMENT-LEVEL COMMENTS (optional)
Not Applicable
Attachments
Original Link
Original Document
Permalink
Disclaimer
EXACT Sciences Corporation published this content on
28 June 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
28 June 2024 19:51:09 UTC.
Exact Sciences Corporation is a global advanced cancer diagnostics company. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. The Company is focusing its research and development efforts on three main areas: Colorectal Cancer Screening, MCED Test Development and MRD Test Development. The Companyâs products and services include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, and OncoExTra Test. The Companyâs flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patientâs breast tumor tissue.